In vivo modification of Abeta plaque toxicity as a novel neuroprotective lithium-mediated therapy for Alzheimer's disease pathology.

In fact, lithium treated PS1xAPP mice displayed an obvious and highly significant decrease (−60.2%) in the NPY positive dystrophic area (Figure 2 D, d1, d2 and d3).

also in 132,142 other papers